Telethon Kids Institute
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
Clinical Trials
83
Active:7
Completed:28
Trial Phases
5 Phases
Phase 1:7
Phase 2:6
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (78 trials with phase data)• Click on a phase to view related trials
Not Applicable
52 (66.7%)Phase 4
9 (11.5%)Phase 1
7 (9.0%)Phase 2
6 (7.7%)Phase 3
4 (5.1%)Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.
Phase 4
Not yet recruiting
- Conditions
- Perioperative Respiratory Adverse EventsAnesthesia Outcomes
- Interventions
- Drug: Decongestant nasal spray (oxymetazoline hydrochloride (0.05%))
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 200
- Registration Number
- NCT07000877
A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children
Recruiting
- Conditions
- Chronic Pain
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 5000
- Registration Number
- NCT06354699
- Locations
- 🇦🇺
Telethon Kids Institute, Perth, Western Australia, Australia
PCV13 in Non-pregnant Papua New Guinean Women
Completed
- Conditions
- Pneumococcal Infections
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 50
- Registration Number
- NCT04183322
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Goroka, Eastern Hghlands Province, Papua New Guinea
Telehealth Support to Increase Physical Activity in Rett Syndrome
Not Applicable
- Conditions
- Rett Syndrome
- First Posted Date
- 2019-11-18
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04167059
- Locations
- 🇩🇰
Center for Rett Syndrom, Rigshospitalet, Copenhagen, Denmark
🇮🇱Ari'el University, Ari'el, Israel
Optimising Rotavirus Vaccine in Aboriginal Children
Phase 4
Active, not recruiting
- Conditions
- Viral Gastroenteritis Due to Rotavirus
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT02941107
- Locations
- 🇦🇺
Menzies School of Health Research, Darwin, Northern Territory, Australia
- Prev
- 1
- 2
- Next
News
No news found